BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 22063269)

  • 1. Regulation of triglyceride metabolism by Angiopoietin-like proteins.
    Mattijssen F; Kersten S
    Biochim Biophys Acta; 2012 May; 1821(5):782-9. PubMed ID: 22063269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of plasma TG lipolysis by Angiopoietin-like proteins and GPIHBP1.
    Lichtenstein L; Kersten S
    Biochim Biophys Acta; 2010 Apr; 1801(4):415-20. PubMed ID: 20056168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism.
    Köster A; Chao YB; Mosior M; Ford A; Gonzalez-DeWhitt PA; Hale JE; Li D; Qiu Y; Fraser CC; Yang DD; Heuer JG; Jaskunas SR; Eacho P
    Endocrinology; 2005 Nov; 146(11):4943-50. PubMed ID: 16081640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL).
    Lee EC; Desai U; Gololobov G; Hong S; Feng X; Yu XC; Gay J; Wilganowski N; Gao C; Du LL; Chen J; Hu Y; Zhao S; Kirkpatrick L; Schneider M; Zambrowicz BP; Landes G; Powell DR; Sonnenburg WK
    J Biol Chem; 2009 May; 284(20):13735-13745. PubMed ID: 19318355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of lipoprotein lipase by Angptl4.
    Dijk W; Kersten S
    Trends Endocrinol Metab; 2014 Mar; 25(3):146-55. PubMed ID: 24397894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triacylglycerol-rich lipoproteins protect lipoprotein lipase from inactivation by ANGPTL3 and ANGPTL4.
    Nilsson SK; Anderson F; Ericsson M; Larsson M; Makoveichuk E; Lookene A; Heeren J; Olivecrona G
    Biochim Biophys Acta; 2012 Oct; 1821(10):1370-8. PubMed ID: 22732211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological regulation of lipoprotein lipase.
    Kersten S
    Biochim Biophys Acta; 2014 Jul; 1841(7):919-33. PubMed ID: 24721265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization.
    Yau MH; Wang Y; Lam KS; Zhang J; Wu D; Xu A
    J Biol Chem; 2009 May; 284(18):11942-52. PubMed ID: 19246456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake.
    Lichtenstein L; Berbée JF; van Dijk SJ; van Dijk KW; Bensadoun A; Kema IP; Voshol PJ; Müller M; Rensen PC; Kersten S
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2420-7. PubMed ID: 17761937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4.
    Sonnenburg WK; Yu D; Lee EC; Xiong W; Gololobov G; Key B; Gay J; Wilganowski N; Hu Y; Zhao S; Schneider M; Ding ZM; Zambrowicz BP; Landes G; Powell DR; Desai U
    J Lipid Res; 2009 Dec; 50(12):2421-9. PubMed ID: 19542565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of angiopoietin-like protein 3 and 4 reveals structural and mechanistic similarities.
    Gunn KH; Gutgsell AR; Xu Y; Johnson CV; Liu J; Neher SB
    J Biol Chem; 2021; 296():100312. PubMed ID: 33482195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiopoietin-like 3 in lipoprotein metabolism.
    Kersten S
    Nat Rev Endocrinol; 2017 Dec; 13(12):731-739. PubMed ID: 28984319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking.
    Zhang R
    Open Biol; 2016 Apr; 6(4):150272. PubMed ID: 27053679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events.
    Miida T; Hirayama S
    Curr Opin Lipidol; 2010 Feb; 21(1):70-5. PubMed ID: 19851103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes.
    Dijk W; Beigneux AP; Larsson M; Bensadoun A; Young SG; Kersten S
    J Lipid Res; 2016 Sep; 57(9):1670-83. PubMed ID: 27034464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms.
    Shan L; Yu XC; Liu Z; Hu Y; Sturgis LT; Miranda ML; Liu Q
    J Biol Chem; 2009 Jan; 284(3):1419-24. PubMed ID: 19028676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase.
    Shimizugawa T; Ono M; Shimamura M; Yoshida K; Ando Y; Koishi R; Ueda K; Inaba T; Minekura H; Kohama T; Furukawa H
    J Biol Chem; 2002 Sep; 277(37):33742-8. PubMed ID: 12097324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice.
    Ando Y; Shimizugawa T; Takeshita S; Ono M; Shimamura M; Koishi R; Furukawa H
    J Lipid Res; 2003 Jun; 44(6):1216-23. PubMed ID: 12671033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics and regulation of angiopoietin-like proteins 3 and 4.
    Li C
    Curr Opin Lipidol; 2006 Apr; 17(2):152-6. PubMed ID: 16531751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids.
    Robciuc MR; Maranghi M; Lahikainen A; Rader D; Bensadoun A; Öörni K; Metso J; Minicocci I; Ciociola E; Ceci F; Montali A; Arca M; Ehnholm C; Jauhiainen M
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1706-13. PubMed ID: 23661675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.